Neotrofin leteprinim (AIT-082): Completed Phase IIb trial enrollment

NeoTherapeutics Inc. (NEOT), Irvine, Calif.
Product: Neotrofin leteprinim (AIT-082)

Read the full 91 word article

How to gain access

Continue reading with a
two-week free trial.